Related Experiment Video
Updated: May 9, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Thyroid MIBG uptake in Parkinson's disease with diabetes mellitus
Wooyoung Jang1, Joong-Seok Kim, Jin Whan Cho
1Department of Neurology, Gangneung Asan Hospital, University of Ulsan, College of Medicine, Bangdong-ri, Sacheon-myeon, Gangneung-si, Gangwon-do, 210-711, Korea.
Abstract:
In our work, we investigated thyroid and cardiac MIBG uptake as potential differential markers. We observed reduced cardiac uptake of MIBG in PD and diabetic CAN, in agreement with the previous studies. However, there was a significant difference between the PD and diabetic cardiac autonomic neuropathy groups with respect to early and delayed thyroid MIBG uptake, in that reduced thyroid MIBG uptake was seen in PD but not in diabetic autonomic neuropathy. We therefore propose that this parameter could be a marker for identifying parkinsonism when it presents together with DM.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Neural Regulation
Hyperthyroidism II: Pathophysiology

